Russell Frank Company’s Edwards Lifesciences EW Stock Holding History

Russell Frank Company’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$42.2M	Buy	1,434,609 +300,450	+26%	+$8.29M	0.07%	292
2015 Q4	$29.9M	Sell	1,134,159 -110,169	-9%	-$2.86M	0.05%	400
2015 Q3	$29.5M	Sell	1,244,328 -202,308	-14%	-$4.88M	0.06%	388
2015 Q2	$34.3M	Sell	1,446,636 -130,662	-8%	-$2.95M	0.06%	387
2015 Q1	$37.5M	Buy	1,577,298 +160,362	+11%	+$3.6M	0.07%	328
2014 Q4	$30M	Buy	1,416,936 +1,065,582	+303%	+$21.4M	0.05%	404
2014 Q3	$5.98M	Buy	351,354 +345,804	+6,231%	+$5.46M	0.01%	1175
2014 Q2	$83K	Sell	5,550 -3,348,000	-100%	-$45.4M	﹤0.01%	2661
2014 Q1	$45.6M	Sell	3,353,550 -110,994	-3%	-$1.28M	0.08%	287
2013 Q4	$37.9M	Buy	3,464,544 +386,988	+13%	+$4.36M	0.07%	318
2013 Q3	$35.7M	Buy	3,077,556 +530,370	+21%	+$6.2M	0.06%	352
2013 Q2	$28.5M	Buy	+2,547,186	New	+$30.2M	0.05%	413

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Russell Frank Company's EW Position: Q1 2016 in Review

Russell Frank Company increased its Edwards Lifesciences (EW) stake by 26% in Q1 2016, buying an estimated $8.29M and bringing the position to 1,434,609 shares worth $42.2M. The position accounts for 0.07% of the portfolio, ranked #292.

Russell Frank Company first reported a position in EW in Q2 2013 and has held it in 12 quarters since. The position peaked at $45.6M in Q1 2014. 659 funds tracked by Wall St. Rank hold EW as of Q1 2016.

Russell Frank Company held 1,434,609 shares of Edwards Lifesciences worth $42.2M as of Q1 2016.
Russell Frank Company bought 300,450 Edwards Lifesciences shares in Q1 2016, an estimated $8.29M.
Edwards Lifesciences made up 0.07% of Russell Frank Company's portfolio in Q1 2016, its #292 holding.
Russell Frank Company first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Edwards Lifesciences position peaked at $45.6M in Q1 2014.
659 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.